Anpario Regulatory News (ANP)

RNS Number : 5009Y

Anpario PLC

05 May 2023

 

 Anpario plc("Anpario" or the "Group")

 

Directorate Change

 

Anpario, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, advises that Kate Allum will step down as Non-Executive Chairman and Chair of the Nomination Committee, leaving the Board at Anpario's AGM on 29 June 2023. Matthew Robinson will take over as Non-Executive Chairman from that date.

 

Kate's decision is due to family health and other commitments which are increasingly requiring more of her time and focus.

 

Kate Allum, stated:

 

"Being a member of the Anpario team has been a privilege and it is with regret that I have made this decision but to do otherwise would be unfair to all stakeholders given the increasing demands on my time elsewhere. Anpario has been a wonderful experience with the highest of ethical and business standards demonstrated by the recent King's Award for Enterprise for Sustainable Development. I am disappointed to have to step away from the role but wish Anpario and its employees the very best of success."

 

 

Richard Edwards, Chief Executive, commented: "Clearly, Kate's decision is disappointing as she has made a significant contribution to Anpario since joining. However, I fully understand her decision and sincerity in ensuring the Board has Non-Executive Directors who are fully able to commit their time to the stewardship of the Company. I would therefore personally, and on behalf of the Board, like to thank Kate for her support, commitment, and guidance during her tenure as Non-Executive Chairman and we send our best wishes for the future."

 

 

A search to appoint a new Non-Executive Director is already underway, the outcome of which will be announced in due course.

 

 

 

 

Enquiries

 

Anpario plc
Richard Edwards, CEO	+44(0)7776 417 129
Marc Wilson, Group Finance Director	+44(0)1909 537 380
Peel Hunt LLP (NOMAD)	+44(0)20 7418 8900
Adrian Trimmings
Andrew Clark
Lalit Bose

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.